New insights on the role of T cells in the pathogenesis of celiac disease.

Despite intense investigation, the pathogenetic mechanisms leading to villous atrophy in Celiac disease (CD) remain not completely understood. The traditional interpretation is that CD4 cells recognize gliadin and develop an inflammatory reaction by production of Th1 cytokines at the mucosa level inducing CD8 cells to kill mucosal cells by a direct cytotoxic mechanism or by Fas-mediated apoptosis. Recent data, however, have shown that novel CD4 T-cells subpopulations, CD4+ CD25+ Regulatory T cells (Tregs) and Th17 cells also play a role in the ongoing inflammatory process. Both Tregs and Th17 cells are increased in active CD. However, because Tregs have a suppressive activity on inflammation, their role is controversial. In this editorial we discuss these recent findings and the hypothesis formulated to explain the increase of Tregs. To understand the pathogenesis of tissue damage of CD, we have focused on the duodenal micro-environment, introducing the new concept of immunological niche that in CD summarizes cellular and cytokine interactions in duodenal mucosa, where a high plasticity of T-cell subsets is present. CD is often complicated by T-cell lymphomas, especially in cases of refractory CD.

[1]  N. Kourda,et al.  Impaired Control of Effector T Cells by Regulatory T Cells: A Clue to Loss of Oral Tolerance and Autoimmunity in Celiac Disease? , 2012, The American Journal of Gastroenterology.

[2]  D. Scadden,et al.  The hematopoietic stem cell niche. , 2012, Frontiers in bioscience.

[3]  M. Neurath,et al.  Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. , 2011, Gastroenterology.

[4]  L. Sollid,et al.  Novel therapies for coeliac disease , 2011, Journal of internal medicine.

[5]  R. Troncone,et al.  IL-15 Interferes With Suppressive Activity of Intestinal Regulatory T Cells Expanded in Celiac Disease , 2011, The American Journal of Gastroenterology.

[6]  A. Goc,et al.  Interleukin-27: Biological Properties and Clinical Application , 2016, Archivum Immunologiae et Therapiae Experimentalis.

[7]  M. Ráki,et al.  HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22 , 2010, Mucosal Immunology.

[8]  D. Pagliari,et al.  Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. , 2010, Journal of biological regulators and homeostatic agents.

[9]  L. Sollid,et al.  Tissue-mediated control of immunopathology in coeliac disease , 2009, Nature Reviews Immunology.

[10]  L. Greco,et al.  A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. , 2009, International immunology.

[11]  E. Ebert Interleukin 21 up‐regulates perforin‐mediated cytotoxic activity of human intra‐epithelial lymphocytes , 2009, Immunology.

[12]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[13]  T. Macdonald,et al.  IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.

[14]  M. Kagnoff Celiac disease: pathogenesis of a model immunogenetic disease. , 2007, The Journal of clinical investigation.

[15]  J. Colgan,et al.  All in the family: IL-27 suppression of TH-17 cells , 2006, Nature Immunology.

[16]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[17]  A. Staiano,et al.  Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease , 2002, Gut.

[18]  E. Thorsby,et al.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. , 1993, Gastroenterology.